Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 2 hrs 48 mins

S&P Futures
6,008.75
+2.25(+0.04%)
Dow Futures
44,843.00
+17.00(+0.04%)
Nasdaq Futures
20,887.25
+7.00(+0.03%)
Russell 2000 Futures
2,441.10
-9.90(-0.40%)
Crude Oil
69.65
+0.71(+1.03%)
Gold
2,629.60
+11.10(+0.42%)

XBiotech Inc. (XBIT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

6.86

+0.03

(+0.44%)

At close: 04:00PM EST

6.86

0.00

(0.00%)

After hours:

04:02PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	209.12M
Enterprise Value	36.00M
Trailing P/E	1.30
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	12.23
Price/Book (mrq)	1.09
Enterprise Value/Revenue	-70.30
Enterprise Value/EBITDA	-1.60

Trading Information

Stock Price History

Beta (5Y Monthly)	N/A
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	9.96
52 Week Low ³	3.60
50-Day Moving Average ³	7.22
200-Day Moving Average ³	7.07

Share Statistics

Avg Vol (3 month) ³	47.34k
Avg Vol (10 day) ³	48.51k
Shares Outstanding ⁵	30.48M
Implied Shares Outstanding ⁶	N/A
Float ⁸	19.84M
% Held by Insiders ¹	35.11%
% Held by Institutions ¹	16.19%
Shares Short (Oct 31, 2024) ⁴	848.3k
Short Ratio (Oct 31, 2024) ⁴	22.55
Short % of Float (Oct 31, 2024) ⁴	4.76%
Short % of Shares Outstanding (Oct 31, 2024) ⁴	2.78%
Shares Short (prior month Sep 30, 2024) ⁴	925.37k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	Jul 23, 2021
Ex-Dividend Date ⁴	Jul 15, 2021
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Sep 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	0.00%

Management Effectiveness

Return on Assets (ttm)	-12.03%
Return on Equity (ttm)	-15.75%

Income Statement

Revenue (ttm)	N/A
Revenue Per Share (ttm)	N/A
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	-40.57M
Net Income Avi to Common (ttm)	-32.66M
Diluted EPS (ttm)	-1.08
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	183.12M
Total Cash Per Share (mrq)	6.01
Total Debt (mrq)	10M
Total Debt/Equity (mrq)	5.20
Current Ratio (mrq)	11.57
Book Value Per Share (mrq)	6.31

Cash Flow Statement

Operating Cash Flow (ttm)	-27.86M
Levered Free Cash Flow (ttm)	-22.16M